Sulfasalazine is an anti-inflammatory medication used in the management of rheumatoid arthritis and inflammatory bowel disease.
Sulfasalazine belongs to a group of medicines known as disease-modifying anti-inflammatory drugs (DMARDs). It is designed to calm inflammation that occurs in certain chronic conditions. In Hong Kong, sulfonamide-based products such as sulfasalazine are prescription-only medicines regulated under the Medicines and Poisons Ordinance.
The active ingredient sulfasalazine is marketed in Hong Kong under both a brand name and its generic form:
Both products are offered in common doses ranging from 500 mg to 1 g per tablet. They are taken orally and are distributed by several pharmaceutical companies that hold licences with the Hong Kong Department of Health. Patients will receive the formulation prescribed by their clinician, whether brand or generic.
Sulfasalazine is recognised for its role in managing several inflammatory disorders:
By reducing the inflammatory response, sulfasalazine helps relieve symptoms like pain, swelling and bowel urgency, allowing patients to maintain a more comfortable daily routine.
Sulfasalazine is a combination of two linked compounds: sulfapyridine and 5-aminosalicylic acid (5-ASA). When the tablet reaches the colon, bacteria break the bond, releasing the two parts. The 5-ASA component acts locally to dampen inflammation, while sulfapyridine is absorbed and contributes to the overall anti-inflammatory effect. This dual action means the medicine works primarily where inflammation is present, typically providing relief within a few weeks of regular use.
Most people experience only mild, temporary reactions, which may include:
These effects often lessen as the body adjusts to the medication.
Although rare, some reactions require immediate medical attention:
If any of these occur, seek urgent care.
People with certain health backgrounds need to discuss sulfasalazine with their prescriber before starting:
Sulfasalazine can interact with other medicines and lifestyle factors:
Patients should review their full medication list with a healthcare professional and read the specific product’s information for detailed interaction guidance.
Store sulfasalazine tablets at room temperature, away from excess moisture and heat. The usual course of treatment may be short-term for flare-ups or longer for chronic conditions, depending on the individual’s disease pattern. Because formulations and strengths differ between Azulfidine and generic sulfasalazine, it is important to follow the instructions that accompany the specific product you receive. For detailed usage, dosing, and administration, refer to your medication’s own information leaflet.
Sulfasalazine: A combined drug that releases anti-inflammatory agents in the colon. 5-Aminosalicylic acid (5-ASA): The component that directly reduces gut inflammation. Sulfapyridine: The companion part of sulfasalazine that helps modulate the immune response.
This article offers general educational information about sulfasalazine as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing sulfasalazine may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
